Medical & Biological Laboratories Co., Ltd. engages in the research, development, manufacture and sale of biological products. It operates through the Reagents and Investment segments. The Reagent segment supplies, manufactures, and sells clinical reagents and research reagents, and its related equipment and instruments. The Investment segment deals with investments on bio-related enterprises and mediates technical partnership. The company was founded on August 23, 1969 and is headquartered in Nagoya, Japan.

Riken Corp. engages in the manufacture and sale of engine and vehicular components. It operates through the Automotive and Machinery Parts, and Others segments. The Automotive and Machinery Parts segment deals with the company's core products such as piston rings, camshafts, seal rings for transmissions, high-grade cast iron products, and valve lifters. The Others segment includes plumbing equipment business, Electromagnetic Compatibility (EMC) business, and thermal engineering business, The company was founded by Masatoshi Okochi in November 1927 and is headquartered in Tokyo, Japan.

Develops anticancer therapies from soil-dwelling micro organisms

Fresenius Kabi Deutschland GmbH, part of Fresenius SE & Co. KGaA, is a company headquartered in Bad Homburg vor der Hohe, Germany, that manufactures drugs in pharmaceutical preparations for human and veterinary use. The firm was founded in 1999. Steffen Roser, Christoph Funke and Tanja Greve are the current co-CEOs of the company.

Thallion Pharmaceuticals Inc. is a biotechnology company focused on developing new pharmaceutical products in the areas of infectious disease and oncology, with a current emphasis on developing a treatment for Shigatoxin-producing E. coli (STEC) bacterial infections. The Company's leading product candidate is Shigamabs®, a dual antibody product for the treatment of Shigatoxin-producing E. coli (STEC) bacterial infections. Thallion has completed four Phase I clinical trials evaluating the safety of Shigamabs®, which demonstrated that the antibodies are safe and well tolerated when administered both individually and in combination. In February, 2010, Thallion signed a definitive development and license agreement with Laboratoire français du Fractionnement et des Biotechnologies (LFB) for payments of up to €95 million, including a €1.5 million upfront payment. LFB received commercial rights to Shigamabs® for Europe, South America and other territories of strategic interest to LFB, including Russia, Turkey, China, South Korea and Northern African countries, while Thallion retained the rights for North America and the rest of world. The Company initiated a Phase II clinical trial in South America in November 2010 to evaluate Shigamabs® as a treatment for STEC infections. The study will comprise up to 17 clinical sites in Argentina, Chile and Peru.

Oriental Yeast Co., Ltd. engages in the manufacture and sale of yeast, raw materials for bread manufacturing, confectionery, noodles, various feeds, biochemistry, and toxicity studies on medicines, food, and others. It is also engages in sales of laboratory animals. Its operations are carried out through the following segments: Food Business and Bioindustry Business. The Food Business segment develops and supplies food ingredients including yeast, flour paste, and mayonnaise. The Bioindustry Business segment produces diagnostic reagent raw materials or reagent in research use, including recombinant enzymes and human proteins. The company was founded on June 30, 1929 and is headquartered in Tokyo, Japan.

Part of Thermo Fisher Scientific, Inc., Pierce Biotechnology, Inc. is an American company located in Rockford, IL. The firm engages in research and development in biotechnology.

Takara Bio USA, Inc. helps to accelerate the discovery process by providing pioneering tools that enable researchers to ask new questions and investigate ever more complex systems than was previously possible. With more than 5,000 literature citations, its innovative products and services continue to facilitate advancement in areas such as genomics, cancer research, apoptosis, cytogenetics, developmental genetics, cellular physiology, pharmocogenetics, and neurobiology.

Nippon Suisan produces and distributes seafood products. It offers fresh and frozen fish and other fish products including fish oil. It is a subsidiary of Nippon Suisan Kaisha Ltd. The company is headquartered in Tokyo, Japan.

Korea Food Research Institute is a global food R&D institution that contributes to the health of Korea.

Acts as an alternative investment manager

Jiangxi Danxia Biotechnology Co., Ltd., established on 2015-05-11, The scope of business includes general food,Health products,Natural colouring,fruit and vegetable concentrate,food additives,Plant extracts,functional food,Flavors and Fragrances,R&D of solid beverage,Production,Sales;Planting of agricultural products,buy,processing,Sales;Self-operated or agent import and export business of the above commodities and technologies***(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Xi'an Keyisi Biotechnology Co., Ltd., established on 2016-08-15, Business scope includes general business items:cosmetic,R&D and sales of chemical raw materials;Technical service and technical consultation;food,Drug development and sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Natreon, Inc.is a company located in New Jersey with a state of the art R&D facility in Kolkata, India, and is focused on developing and marketing Ayurvedic products backed by extensive research, high degree of standardization, multiple clinical studies, safety studies, and intellectual property.

Anhui Haotuo Biotechnology Co., Ltd., established on 2018-07-13, Business scope includes bioengineering and biomedicine,Technology research and development related to medical devices,Technology Transfer and Consulting Services,Related Reagents,Consumables,Instrument R&D,production and sales,Chemical Products(Removal of hazardous chemicals,highly toxic chemicals,precursor chemicals)promotion of,Engaged in the import and export of goods or technology.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)**